Paocharoen Veeraya
Department of Surgery, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
J Med Assoc Thai. 2010 Dec;93 Suppl 7:S166-70.
To study clinical efficacy and side effects of the oral Centella asiatica extract capsule in the diabetic wound healing. And to study the side effects of Centella asiatica extract capsule.
This prospective randomized control study enrolled two hundred diabetic patients in the department of Surgery, Thammasat University Hospital. The exclusion criterion were low immune patients, oral steroid intake, age more than 80 year and less than 18 yeas, serum albumin less than 3.0 gm/dl, uncorrected peripheral arterial diseased patients, and uncontrolled infective wound. The termination criterion were patient refusal, wound infection, delayed primary sutured wound secondary healing wound. The patients were divided into two groups randomly, groupA was Centella asiatica extract capsule group and group B was placebo group. Centella asiatica extract capsule and placebo were prescribed in each group under the random sheet. The administration was 2 capsules after meal, three times a day (50 mg of extracted asiaticoside / capsule in group A). The general symptoms, wound characteristics, wound size and depth were examined at day 7, day 14 and day 21 by the same investigator. The demographic data of the sample were analyzed by student t test and comparative wound characteristics were analyzed by Pearson Chi-Square test.
Wound contraction in the study group is better than placebo group but granulation tissue forming is better in the placebo group. No serious adverse reaction in both groups.
Centella asiatica extract capsule is the Thai herb preparation capsule that effective in the wound healing promotion and also suppress the scar in diabetic wound patients. There was no demonstrable serious side effect of the Centella asiatica extract capsule group. Centella asiatica extract capsule can shorten the course of diabetic wound and can be prescribed to the diabetic patients safely.
研究口服积雪草提取物胶囊对糖尿病伤口愈合的临床疗效及副作用。并研究积雪草提取物胶囊的副作用。
这项前瞻性随机对照研究纳入了泰国国立法政大学医院外科的200名糖尿病患者。排除标准为免疫功能低下患者、口服类固醇药物、年龄超过80岁或低于18岁、血清白蛋白低于3.0 gm/dl、未矫正的外周动脉疾病患者以及未控制的感染性伤口。终止标准为患者拒绝、伤口感染、延迟一期缝合伤口、二期愈合伤口。患者被随机分为两组,A组为积雪草提取物胶囊组,B组为安慰剂组。根据随机表在每组中开具积雪草提取物胶囊和安慰剂。给药方式为饭后服用2粒胶囊,每日3次(A组每粒胶囊含50mg积雪草苷提取物)。由同一名研究者在第7天、第14天和第21天检查一般症状、伤口特征、伤口大小和深度。样本的人口统计学数据采用学生t检验进行分析,比较伤口特征采用Pearson卡方检验进行分析。
研究组伤口收缩情况优于安慰剂组,但安慰剂组肉芽组织形成情况更好。两组均未出现严重不良反应。
积雪草提取物胶囊是一种泰国草药制剂胶囊,对促进糖尿病伤口愈合有效,且能抑制糖尿病伤口患者的瘢痕形成。积雪草提取物胶囊组未显示出明显的严重副作用。积雪草提取物胶囊可缩短糖尿病伤口病程,可安全地开给糖尿病患者。